AEON

AEON Biopharma, Inc. Class A Common Stock (AEON)

About AEON Biopharma, Inc. Class A Common Stock (AEON)

AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.

Details

Daily high

$1.12

Daily low

$1.04

Price at open

$1.06

52 Week High

$45.29

52 Week Low

$0.38

Market cap

12.2M

Dividend yield

0.00%

Volume

133,922

Avg. volume

167,476

P/E ratio

.20

AEON Biopharma, Inc. Class A Common Stock News